BR Pharm

BR Pharm is committed to relying on the core technology of PDRN product manufacturing to engage in research in the field of regenerative medicine, creating a more beautiful and comfortable life for all humanity.To ensure the production of regenerative medicine products, BR Pharm holds the manufacturing technology for PDRN, a cellular regenerative active substance drug. It has completed the DMF registration for the active pharmaceutical ingredient (PDRN) and obtained BGMP (Excellent Active Pharmaceutical Ingredient Manufacturing and Quality Management Standards) certification from the Ministry of Food and Drug Safety. In addition, the company is actively working on ensuring the safe and independent supply of raw materials for PDRN active pharmaceutical ingredients by signing cooperation agreements with international organizations.